108768 ⎘
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor; Animal cells or tissues; Human cells or tissues; Vertebrate cells; Cells from the blood or the immune system; T lymphocytes Immunosuppressive T lymphocytes, e.g. regulatory T cells (Treg)
SYSTEMS AND METHODS FOR CELL CULTURING
#2SINGLE-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOF
#3SYSTEMS AND METHODS FOR CELL CULTURING
#4CHIMERIC ANTIGEN RECEPTORS FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND DISORDERS
#5MEANS TO TREAT AUTOIMMUNITY BY REFINING REGULATORY T CELLS
#6T CELL PRODUCTION METHOD
#7Drug-Resistant Immune Cells and Methods of Use Thereof
#8COMPOSITIONS COMPRISING REGULATORY T CELLS AND METHODS OF USING THE SAME
#9CITRULLINATED ANTIGEN-SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR TARGETING REGULATORY T CELLS TO TREAT HIDRADENITIS SUPPURATIVA
#10INTRATHECAL ADMINISTRATION OF T REGULATORY CELLS IN THE TREATMENT OF MULTIPLE SCLEROSIS
#11CHIMERIC ANTIGEN RECEPTORS AGAINST MULTIPLE HLA-G ISOFORMS
#12IDENTIFICATION OF HIGHLY IMMUNOSUPRESIVE TREG POPULATION IN TUMOR MICROENVIRONMENTS
#13MARKERS SELECTIVELY DEREGULATED IN TUMOR-INFILTRATING REGULATORY T CELLS
#14Induction and Expansion of Regulatory T Cells
#15NONCODING RNA AGENTS (BCYRN1 AND DERIVATIVES THEREOF) TO TREAT DISEASES OF IMMUNITY
#16METHODS OF IMPROVING CELLULAR THERAPY WITH ORGANELLE COMPLEXES
#17COMPOSITIONS COMPRISING REGULATORY T CELLS AND METHODS OF MAKING AND USING THE SAME
#18CELL THERAPIES FOR MULTIPLE SCLEROSIS
#19RECOMBINANT CYTOKINE RECEPTORS AND METHODS OF USE
#20BI-SPECIFIC TARGETED CHIMERIC ANTIGEN RECEPTOR T CELLS
#21COMPOSITION FOR ELICITING INFECTIOUS IMMUNOLOGICAL TOLERANCE
#22Methods of Genetically Modifying Cells for Altered Codon-Anti-Codon Interactions
#23GENETIC ENGINEERING OF ENDOGENOUS PROTEINS
#24MODIFIED CD4+ T CELLS EXPRESSING IL-37 AND METHODS OF USE THEREOF
#25TARGETED REPLACEMENT OF ENDOGENOUS T CELL RECEPTORS
#26FUSION PROTEIN FOR MAINTENANCE OF REGULATORY T-CELLS
#27PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING T CELL-RELATED DISORDERS
#28SYSTEMS AND METHODS FOR CELL CULTURING
#29ENGINEERED REGULATORY T CELLS
#30TETHERED INTERLEUKIN-2 RECOMBINANT RECEPTORS AND METHODS OF USE
#31CTLA-4 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
#32Methods to Expand a T Regulatory Cell Master Cell Bank
#33METHOD FOR MAINTAINING SUPPRESSIVE ACTIVITY OF REGULATORY T CELLS
#34MODIFIED BINDING PROTEINS AND THERAPEUTIC USES THEREOF
#35OPTIMIZED METHOD FOR EXPANSION AND LARGE-SCALE PRODUCTION OF REGULATORY T CELLS (Tregs)
#36METHOD FOR IN VITRO EXPANSION OF CRYOPRESERVED CORD BLOOD-DERIVED REGULATORY T CELLS (Tregs) WITH HIGH RECOVERY RATE
#37REGULATORY T CELL STABILITY ASSAY
#38MARKERS SELECTIVELY DEREGULATED IN TUMOR-INFILTRATING REGULATORY T CELLS
#39CULTURE METHOD
#40COMPOSITIONS AND METHODS FOR IDENTIFICATION OF ANTIGEN SPECIFIC T CELLS
#41SELECTIVE EXPANSION OF DIFFERENT SUBPOPULATIONS OF T CELLS BY THE ALTERATION OF CELL SURFACING SIGNALS AND SIGNAL RATIO
#42CHIMERIC ANTIGEN RECEPTOR MODIFIED REGULATORY T CELLS FOR TREATING CANCER
#43METHOD FOR PRODUCING REGULATORY T CELLS
#44POLY-DONOR CD4+ T CELLS EXPRESSING IL-10 AND USES THEREOF
#45IMMUNE CELL SELECTION, EXPANSION, AND USE
#46COMPOSITIONS AND METHODS FOR ENGINEERING TREG CELLS FOR TREATMENT OF DIABETES
#47CELL
#48STABLE REGULATORY T CELLS AND METHODS OF PRODUCTION
#49ARTIFICIAL ANTIGEN-SPECIFIC IMMUNOREGULATORY T (AIRT) CELLS
#50REGULATORY T CELLS WITH CHIMERIC ANTIGEN RECEPTOR TARGETING CO-STIMULATORY MOLECULES TO PREVENT AND/OR TREAT INFLAMMATORY CONDITIONS
#51METHODS AND PRODUCTS FOR CULTURING T CELLS AND USES THEREOF
#52THERAPIES WITH LANTHIONINE C-LIKE PROTEIN 2 LIGANDS AND CELLS PREPARED THEREWITH
#53ENGINEERED REGULATORY T CELL
#54Method for Generating Regulatory T Cells
#55Cell Expansion
#56ENGINEERED IMMUNE CELLS WITH DOMINANT SIGNALS
#57PEPTIDE
#58INTERACTION OF FIBROBLASTS AND IMMUNE CELLS FOR ACTIVATION AND USES THEREOF
#59METHODS OF PROTECTING IMPLANTED OR TRANSPLANTED CELLS AND TISSUES FROM IMMUNE REJECTION
#60NUCLEIC ACID CONSTRUCTS FOR EXPRESSING POLYPEPTIDES IN CELLS
#61PRODUCTION METHOD FOR T CELLS OR NK CELLS, MEDIUM FOR CULTURING T CELLS OR NK CELLS, METHOD FOR CULTURING T CELLS OR NK CELLS, METHOD FOR MAINTAINING UNDIFFERENTIATED STATE OF UNDIFFERENTIATED T CELLS, AND GROWTH-ACCELERATING AGENT FOR T CELLS OR NK CELLS
#62COMPOSITIONS AND METHODS FOR ENGINEERING STABLE TREGS
#63METHODS OF PREPARING AN ISOLATED OR PURIFIED POPULATION OF THYMIC EMIGRANT CELLS AND METHODS OF TREATMENT USING SAME
#64T CELL RECEPTORS
#65AUGMENTATION OF CELL THERAPY EFFICACY INCLUDING TREATMENT WITH ALPHA, 1,3 FUCOSYLTRANSFERASE
#66ALS TREATMENT USING INDUCED REGULATORY T (ITREG) CELLS
#67IMMUNOMODULATORY FUSION PROTEINS AND USES THEREOF
#68IMMUNOSUPPRESSIVE ANTIGEN-SPECIFIC CHIMERIC ANTIGEN RECEPTOR TREG CELLS FOR PREVENTION AND/OR TREATMENT OF AUTOIMMUNE AND ALLOIMMUNE DISORDERS
#69Gammadelta T Cell Expansion Procedure
#70CHIMERIC ANTIGEN RECEPTOR SPECIFIC FOR INTERLEUKIN-23 RECEPTOR
#71MODIFIED REGULATORY T CELLS AND METHODS OF USING THE SAME
#72T CELL RECEPTORS FOR IMMUNOTHERAPY
#73ISOLATION OF STABLE REGULATORY T CELLS AND USES THEREOF
#74AGENTS AND METHODS FOR PREVENTING OR INHIBITING ADAPTIVE IMMUNE RESPONSES ASSOCIATED WITH MULTIPLE SCLEROSIS
#75Systems and Methods Incorporating Modified T-Cells
#76METHODS OF TREATING AGE-RELATED AND INFLAMMATORY DISEASES
#77PROSTATE CANCER CHIMERIC ANTIGEN RECEPTORS
#78Immunosuppressive Antigen-Specific Chimeric Antigen Receptor Treg Cells for Prevention and/or Treatment of Autoimmune and Alloimmune Disorders
#79SYSTEMS AND METHODS FOR CELL CULTURING
#80REGULATORY T CELLS TARGETED BY LYMPHOTOXIN ALPHA BLOCKING AGENT AND USES THEREOF
#81Creation of Inducible Pluripotent Stem Cell Derived T Regulatory Cells by In Vitro Recapitulation ofThymic Development
#82CHIMERIC ANTIGEN RECEPTORS WITH MUTATED DAP10 COSTIMULATORY DOMAINS
#83COMPOSITIONS AND METHODS FOR CONTROLLING CELL SIGNALING WITH CHIMERIC RECEPTORS
#84COMPOSITIONS AND METHODS FOR HEMATOPOIETIC STEM CELL TRANSPLANTS
#85Peptide Activating Agent
#86HUMAN INDUCIBILITY CONTROLLABLE T-CELL AND METHOD FOR PREPARING SAME
#87PREPARATION OF A THERAPEUTIC COMPOSITION FOR TREATING AUTOIMMUNE DISEASES
#88METHOD OF TREATING A TUMOR EXPRESSING CARBONIC ANHYDRASE IX (G250) BY ADMINISTERING A G250-SPECIFIC CHIMERIC ANTIGEN RECEPTOR
#89Enhanced Mobility of Inducible Pluripotent Stem Cell Derived T Regulatory Cells
#90CELLULAR POPULATIONS AND USES THEREOF
#91IL5RA CELL SURFACE MARKERS
#92CONVERSION-RESISTANT / CONDITION-RESISTANT TREGS AND CAR TREGS, METHODS OF MAKING AND METHODS OF USING
#93METHOD FOR PRODUCING T CELL
#94METHODS AND COMPOSITIONS FOR TARGETING TREG CELLS
#95GENE TARGETS FOR MANIPULATING T CELL BEHAVIOR
#96ANTI-TREM2 CHIMERIC ANTIGEN RECEPTOR
#97METHOD FOR ENHANCING THE SUPPRESSIVE PROPERTIES OF TREG CELLS
#98SYSTEMS AND METHODS FOR CELL CULTURING
#99Synergistic Inhibition of eIF5A and Notch Signaling in Intermediate Tregs
#100METHODS OF TREATMENT
#101SYSTEMS AND METHODS FOR CELL CULTURING
#102SINGLE-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOF
#103Methods for Producing Regulatory T Cell (Treg) Populations, Treg Compositions and Methods for Treatment
#104METHODS AND COMPOSITIONS FOR ENHANCING THE CYTOTOXICITY OF GAMMA/DELTA-T CELLS
#105HLA-A2-SPECIFIC REGULATORY T CELLS
#106METHODS FOR CREATING REGULATORY T CELLS (TREGS) USING GENOME ENGINEERING
#107METHODS FOR ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
#108CHIMERIC ANTIGEN RECEPTOR
#109REGULATORY T CELL EPITOPES
#110Regulatory T Cell (Treg) Extracellular Vesicle Compositions and Methods
#111MANIPULATED IMMUNOREGULATORY ELEMENT AND IMMUNITY ALTERED THEREBY
#112ENGINEERED IMMUNE CELLS WITH RECEPTOR SIGNAL STRENGTH MODULATED BY A HINGE
#113Individualized Cell Therapy Using Patient-Derived Antigen-Specific Regulatory T Cells
#114AUGMENTATION OF CELL THERAPY EFFICACY INCLUDING TREATMENT WITH ALPHA 1,3 FUCOSYLTRANSFERASE
#115CHIMERIC ANTIGEN RECEPTORS AND MODIFIED CELLS COMPRISING THE SAME
#116ENGINEERED IMMUNE CELLS WITH RECEPTOR CROSS-TALK
#117METHODS FOR EXPANDING REGULATORY T CELLS
#118GENETICALLY MODIFIED GENES AND CELLS, AND METHODS OF USING SAME FOR SILENCING VIRUS GENE EXPRESSION
#119METHODS FOR EXPANSION OR DEPLETION OF T-REGULATORY CELLS
#120BI-SPECIFIC ANTIBODIES FOR USE IN PRODUCING ARMED IMMUNE CELLS
#121THERAPEUTIC VACCINE FOR TREATMENT OF DIABETES TYPE 1 IN CHILDREN, APPLICATION OF THE CELL SORTER AND THE METHOD OF MULTIPLYING TREG CELLS TO PRODUCE THERAPEUTIC VACCINE FOR TREATMENT OF DIABETES TYPE 1
#122METHOD FOR EX-VIVO EXPANSION OF REGULATORY T CELLS WITH ENHANCED SUPPRESSIVE FUNCTION FOR CLINICAL APPLICATION IN IMMUNE MEDIATED DISEASES
#123METHOD OF PRODUCING REGULATORY T CELLS BY CULTURING REGULATORY T CELLS OBTAINED FROM UMBILICAL CORD BLOOD
#124Methods to Expand a T Regulatory Cell Master Cell Bank
#125METHOD FOR LARGE-SCALE PRODUCTION OF HUMAN ALLOSPECIFIC INDUCED-REGULATORY T CELLS WITH FUNCTIONAL STABILITY IN THE PRESENCE OF PRO-INFLAMMATORY CYTOKINES WITH THERAPEUTIC POTENTIAL IN TRANSPLANTATION
#126PLURIPOTENT STEM CELL-DERIVED HEMATOPOIETIC LINEAGES
#127METHODS TO PROTECT TRANSPLANTED TISSUE FROM REJECTION
#128CTLA-4 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
#129MATERIALS AND METHODS FOR INDUCING REGULATORY T CELLS
#130BI-SPECIFIC TARGETED CHIMERIC ANTIGEN RECEPTOR T CELLS
#131Induction of IL-12 using immunotherapy
#132GENETICALLY MODIFIED ANTI-THIRD PARTY CENTRAL MEMORY T CELLS AND USE OF SAME IN IMMUNOTHERAPY
#133METHODS AND COMPOSITIONS FOR MODULATING PERIPHERAL IMMUNE FUNCTION
#134METHODS FOR EXPANDING REGULATORY T CELLS
#135GENETICALLY MODIFIED GENES AND CELLS, AND METHODS OF USING SAME FOR SILENCING VIRUS GENE EXPRESSION
#136ANTIBODIES, COMBINATIONS COMPRISING ANTIBODIES, BIOMARKERS, USES & METHODS
#137EXPRESSION OF FOXP3 IN EDITED CD34+ CELLS
#138ANTI-C4D CHIMERIC ANTIGEN RECEPTOR REGULATORY T CELLS AND USES THEREOF
#139Cell
#140ENHANCEMENT OF ADOPTIVE CELL TRANSFER
#141INDUCIBLE SIGNALLING PROTEIN
#142NOVEL METHOD FOR PRODUCING ANTIBODIES
#143Cell
#144CELL
#145Expanding Cells In A Bioreactor
#146MODULATING BHLHE40 IN THE DIFFERENTIATION OF TYPE 1 REGULATORY T CELLS AND CONTROLLING T CELL EXHAUSTION
#147OVERCOMING TNF-ALPHA BLOCKADE RESISTANCE IN RHEUMATOID ARTHRITIS BY REGENERATIVE T REGULATORY CELL THERAPY
#148BIOTIN DERIVATIVES
#149CS1 TARGETED CHIMERIC ANTIGEN RECEPTOR-MODIFIED T CELLS
#150METHOD FOR CRYOPRESERVING ENGINEERED TREGS
#151Augmentation of Cell Therapy Efficacy Including Treatment with Alpha 1,3 Fucosyltransferase
#152USE OF INSULIN-LIKE GROWTH FACTORS WITH GAMMA-CHAIN CYTOKINES TO INDUCE HOMEOSTATIC PROLIFERATION OF LYMPHOCYTES
#153IL-23R antagonists to reprogram intratumoral T regulatory cells into effector cells
#154METHOD FOR DETECTING IMMUNE EFFICACY AND METHOD OF TREATING A CANCER
#155ICOS CRITICALLY REGULATES THE EXPANSION AND FUNCTION OF INFLAMMATORY HUMAN TH17 CELLS
#156VETO CELLS GENERATED FROM MEMORY T CELLS
#157ENHANCED IMMUNE CELLS USING DUAL SHRNA AND COMPOSITION INCLUDING THE SAME
#158Markers selectively deregulated in tumor-infiltrating regulatory T cells
#159Compositions for Preparing Regulatory T-Cell Compositions for the Treatment of Autoimmune Disease
#160PROTECTION FROM OVARIAN FAILURE BY LOW DOSE INTERLEUKIN-2 ADMINISTRATION
#161NOVEL T CELLS AND THE USES THEREOF
#162PROGRAMMING OF REGULATORY T CELLS BY EXTRACELLULAR VESICLES
#163EX VIVO EXPANSION OF REGULATORY T CELLS FOR SUPPRESSION OF GRAFT VERSUS HOST DISEASE
#164OX40L-JAGGED-1 CHIMERIC POLYPEPTIDES AND USES THEREOF
#165Expanding Cells In A Bioreactor
#166CELLULAR POPULATIONS AND USES THEREOF
#167POPULATION OF TREG CELLS FUNCTIONALLY COMMITTED TO EXERT A REGULATORY ACTIVITY AND THEIR USE FOR ADOPTIVE THERAPY
#168GAMMADELTA T CELL EXPANSION PROCEDURE
#169REGULATORY T CELL EPITOPES
#170MYELIN OLIGODENDROCYTE GLYCOPROTEIN-SPECIFIC PEPTIDE FOR THE TREATMENT OR PREVENTION OF MULTIPLE SCLEROSIS
#171TARGETED REPLACEMENT OF ENDOGENOUS T CELL RECEPTORS
#172TARGETING OF SRC-3 IN IMMUNE CELLS AS AN IMMUNOMODULATORY THERAPEUTIC FOR THE TREATMENT OF CANCER
#173ARTIFICIAL ANTIGEN-SPECIFIC IMMUNOREGULATORY T (AIRT) CELLS
#174COMPOSITIONS AND METHODS FOR PERFORMING MAGNETIBUOYANT SEPARATIONS
#175REGULATORY T CELLS GENETICALLY MODIFIED FOR THE LYMPHOTOXIN ALPHA GENE AND USES THEREOF
#176Chimeric antigen receptors against multiple HLA-G isoforms
#177CTLA-4 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
#178METHOD OF INDUCING REGULATORY T CELLS
#179METHODS OF USE OF ALLERGEN-SPECIFIC T CELLS IN ALLERGY AND ASTHMA
#180Regulatory T cell epitopes
#181Compositions and methods for identification of antigen specific T cells
#182IMMUNOSUPPRESSANT-RESISTANT T-CELLS FOR ADOPTIVE IMMUNOTHERAPY
#183ENGINEERED REGULATORY T CELL
#184METHOD FOR EXPANSION OF DOUBLE NEGATIVE REGULATORY T CELLS
#185GENERATION OF AUTOIMMUNE INHIBITORY T CELLS BY FIBROBLAST MEDIATED EDUCATION
#186Compound, And Method For Producing Regulatory T Cells
#187Method for Identifying Functional Disease-Specific Regulatory T Cells
#188CRISPR-BASED FOXP3 GENE ENGINEERED T CELLS AND HEMATOPOIETIC STEM CELL PRECURSORS TO TREAT IPEX SYNDROME PATIENTS
#189Systems and Methods for Producing Efficacious Regulatory T Cells
#190REGULATORY T CELL (TREG) COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE
#191INTERLEUKIN-2 IN COMBINATION WITH TNF RECEPTOR FAMILY MEMBERS FOR THE EXPANSION OF T-REGULATORY CELLS
#192SYSTEMS AND METHODS FOR CELL CULTURING
#193Single-chain chimeric polypeptides and uses thereof
#194Systems and methods for cell culturing
#195Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment
#196Single-chain chimeric polypeptides and uses thereof
#197METHODS FOR ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
#198COMPOSITIONS AND METHODS FOR IN VITRO CULTIVATION AND/OR EXPANSION OF REGULATORY T CELLS
#199GENERATION OF ENGINEERED REGULATORY T CELLS
#200Detection of a defect on HLA-E restricted CD8+ T regulatory cells
#201Method for treating type I diabetes with peptide-loaded dendritic cells
#202Method for treating multiple sclerosis with peptide-loaded dendritic cells
#203ENGINEERED REGULATORY T CELL
#204CHIMERIC ANTIGEN RECEPTOR ANTI-INFLAMMATORY CELLS AND METHODS OF USE
#205Enhanced immune cells using dual shRNA and composition including the same
#206MATERIALS AND METHODS FOR MODIFYING THE ACTIVITY OF T CELLS
#207COMPOSITION FOR CULTURING PERIPHERAL BLOOD MONOCYTE-DERIVED REGULATORY T CELL AND REGULATORY T CELL CULTURING METHOD USING SAME
#208AUXOTROPHIC SELECTION METHODS
#209Method of producing regulatory T cells by culturing regulatory T cells obtained from umbilical cord blood
#210Cell populations having immunoregulatory activity, method for isolation and uses
#211METHOD FOR OBTAINING REGULATORY T CELLS DERIVED FROM THYMIC TISSUE AND USE OF SAID CELLS AS CELL IMMUNOTHERAPY IN IMMUNE SYSTEM DISORDERS
#212Systems and methods for cell culturing
#213COMPOSITIONS COMPRISING REGULATORY T CELLS AND METHODS OF USING THE SAME
#214COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF BLADDER CANCER
#215COMPOSITIONS AND METHODS FOR PREPARING T CELL COMPOSITIONS AND USES THEREOF
#216Chimeric antigen receptors against multiple HLA-G isoforms
#217CAR-T CELLS SPECIFIC FOR MODIFIED PROTEINS IN EXTRACELLULAR SPACES
#218SELECTIVE EXPANSION OF DIFFERENT SUBPOPULATIONS OF T CELLS BY THE ALTERATION OF CELL SURFACING SIGNALS AND SIGNAL RATIO
#219FOXP3 ENGINEERED CD4+ T CELLS FOR USE IN TREG-BASED IMMUNOTHERAPY
#220ALLOGENIC CAR-T CELL THERAPY
#221SPHINGOLIPIDS FOR GENERATING REGULATORY CD4+ T CELLS
#222Regulatory T cells targeted by lymphotoxin alpha blocking agent and uses thereof
#223MANIPULATION AND USE OF ANTIGEN-SPECIFIC REGULATORY T CELLS
#224Systems and methods for cell culturing
#225TREATMENT OF KIDNEY FAILURE USING EX VIVO REPROGRAMMED IMMUNE CELLS
#226INTERLEUKIN-2 AGENTS AND USES THEREOF
#227REPROGRAMMING OF LIPID METABOLISM TO INHIBIT T CELL SENESCENCE AND ENHANCE TUMOR IMMUNOTHERAPY
#228BEAD-FREE EX-VIVO EXPANSION OF HUMAN REGULATORY T CELLS
#229Prostate cancer chimeric antigen receptors
#230THREE-DIMENSIONAL PRINTED ORGANS, DEVICES, AND MATRICES
#231Tagged chimeric effector molecules and receptors thereof
#232Generation of type 1 regulatory T cells through transcription factor targeting
#233Targeting of SRC-3 in immune cells as an immunomodulatory therapeutic for the treatment of cancer
#234Targeting of SRC-3 in immune cells as an immunomodulatory therapeutic for the treatment of cancer
#235MUC1 PARALLEL CAR (pCAR) THERAPEUTIC AGENTS
#236METHOD FOR LARGE-SCALE PRODUCTION OF ALLOSPECIFIC TYPE 1 REGULATORY TREGS (TR1) STABLE IN THE PRESENCE OF PROINFLAMMATORY CYTOKINES WITH THERAPEUTIC POTENTIAL IN TRANSPLANTATION
#237Targeting of SRC-3 in immune cells as an immunomodulatory therapeutic for the treatment of cancer
#238EX VIVO GENERATION OF GAMMA DELTA FOXP3+ REGULATORY T CELLS AND THERAPEUTIC USES THEREOF
#239CHEMOKINE EXPRESSING CELL AND USE THEREOF
#240CONTROLLING PROXIMITY OF IMMUNE CELL RECEPTORS
#241ENGINEERED IMMUNE CELLS WITH MICRO-CLUSTERS
#242ENGINEERED IMMUNE CELLS WITH MULTIPLEX AND LOCALIZED ACTIVITY
#243Engineered immune cells with receptor cross-talk
#244ENGINEERING IMMUNE CELLS BASED ON ANTIGEN LEVELS
#245Engineered immune cells with receptor signal strength modulated by a hinge
#246Engineered immune cells with dominant signals
#247Genetically modified anti-third party central memory T cells and use of same in immunotherapy
#248MODULATABLE SWITCH FOR SELECTION OF DONOR MODIFIED CELLS
#249Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith
#250TREATMENT METHOD FOR GRAFT-VERSUS-HOST DISEASE
#251ISOLATED MHC-DERIVED HUMAN PEPTIDES AND USES THEREOF FOR STIMULATING AND ACTIVATING THE SUPPRESSIVE FUNCTION OF CD8+CD45RCLOW TREGS
#252IMMUNOTHERAPEUTIC METHODS AND COMPOSITIONS
#253METHOD FOR EX-VIVO EXPANSION OF REGULATORY T CELLS WITH ENHANCED SUPPRESSIVE FUNCTION FOR CLINICAL APPLICATION IN IMMUNE MEDIATED DISEASES
#254ANTIGEN-SPECIFIC T CELLS FOR INDUCING IMMUNE TOLERANCE
#255MIRNA FOR USE IN THERAPY
#256USE OF CD26 AND CD39 AS NEW PHENOTYPIC MARKERS FOR ASSESSING MATURATION OF FOXP3+ T CELLS AND USES THEREOF FOR DIAGNOSTIC PURPOSES
#257RECOMBINANT VECTORS SUITABLE FOR THE TREATMENT OF IPEX SYNDROME
#258Production method for T cells or NK cells, medium for culturing T cells or NK cells, method for culturing T cells or NK cells, method for maintaining undifferentiated state of undifferentiated T cells, and growth-accelerating agent for T cells or NK cells
#259COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#260Cell surface modification by coating with peptide amphiphiles (PAs)
#261Immunosuppressive antigen-specific chimeric antigen receptor Treg cells for prevention and/or treatment of autoimmune and alloimmune disorders
#262ENGINEERED REGULATORY T CELLS
#263Methods of producing T cell populations enriched for stable regulatory T-cells
#264T Cells with Improved Mitochondrial Function
#265Chimeric antigen receptors against multiple HLA-G isoforms
#266Immunomodulatory fusion proteins and uses thereof
#267Chimeric polypeptides and methods of altering the membrane localization of the same
#268Interaction of fibroblasts and immune cells for activation and uses thereof
#269USE OF APOPTOTIC CELLS EX VIVO TO GENERATE REGULATORY T CELLS
#270BI-SPECIFIC TARGETED CHIMERIC ANTIGEN RECEPTOR T CELLS
#271Chimeric antigen receptor specific for interleukin-23 receptor
#272INDUCED REGULATORY T CELLS, METHODS OF PRODUCTION, AND USES THEREOF
#273METHOD FOR AMPLIFYING ANTIGEN-SPECIFIC REGULATORY T CELLS IN VITRO
#274Structural and functional characteristics of yeast-derived polysaccharide inducing Treg cell
#275CRISPR ASSOCIATED PROTEIN REACTIVE T CELL IMMUNITY
#276Materials and methods for inducing regulatory T cells
#277METHOD FOR EX VIVO EXPANSION OF REGULATORY T CELLS
#278GENETICALLY REPROGRAMMED TREGS EXPRESSING MEMBRANE-BOUND IL-10
#279Steroid compounds as Treg modulators and uses thereof
#280COMPOSITIONS AND METHODS FOR MODIFYING REGULATORY T CELLS
#281ENGINEERED REGULATORY T CELL
#282Methods of treating age-related and inflammatory diseases
#283Compositions and methods of treating cancer with chimeric antigen receptors
#284T CELL RECEPTORS
#285COMPOSITIONS AND METHODS FOR IMMUNOSUPPRESSION
#286METHODS AND COMPOSITIONS FOR INCREASING THE SUPPRESSIVE FUNCTION OF REGULATORY T-CELLS (TREGS)
#287ENHANCEMENT OF ADOPTIVE CELL TRANSFER
#288Regulatory T cell epitopes
#289USE OF PDL1 EXPRESSING CELLS TO CONVERT T CELLS INTO REGULATORY T CELLS
#290PRODUCTION OF ENGINEERED DENDRITIC CELLS AND USES THEREOF
#291TRANSFORMING GROWTH FACTOR-BETA-RESPONSIVE POLYPEPTIDES AND THEIR METHODS FOR USE
#292ALS treatment using induced regulatory T (iTREG) cells
#293MoT cells as a therapeutic screening tool for regulatory t-cell activity
#294Induction of IL-12 using immunotherapy
#295METHODS OF ACTIVATING REGULATORY T CELLS
#296Method for eliciting infectious immunological tolerance
#297ANTIBODY CAPABLE OF INDUCING IMMUNE TOLERANCE PRODUCED USING CELL MIXTURE HAVING COMPLEXED STATE, AND INDUCED LYMPHOCYTE OR CELL THERAPEUTIC AGENT AND CELL THERAPY METHOD EACH USING INDUCED LYMPHOCYTE
#298REAGENTS AND METHODS FOR IDENTIFYING, ENRICHING, AND/OR EXPANDING ANTIGEN-SPECIFIC T CELLS
#299Compositions and methods of hematopoietic stem cell transplants
#300Method for Generating Regulatory T Cells